Events

Presenter: Stephen Hurly, President and Chief Executive Officer, LAVA Therapeutics
Presentation Date: Thursday, March 17, 2022
Presentation Time: 8:40 – 9:10 a.m. ET.

Conference Website

Presentation: "Bispecific Antibodies and Gamma Delta T Cell Engagers for the Treatment of Cancer"
Presentation Date: Thursday, March 17, 2022
Presentation Time: 8:05 – 8:30 p.m. PT

Conference Website

Speaker/Participant: Paul W.H.I. Parren, Ph.D., Executive Vice President, Head of Research & Development, LAVA Therapeutics

Activities:
Thursday, Mar. 10, 2022
10:40 a.m. PT / 1:40 p.m. ET
Session Chair: Antibodies for Immunotherapy
 
2:40 p.m. PT / 5:40 p.m. ET
Presentation: A bispecific gamma-delta T cell engager targeting CD1d for the treatment of hematological cancers
 
Friday, Mar. 11, 2022
2:40 p.m. PT / 5:40 p.m. ET
Closing Keynote panel discussion participant: Exploring clinical needs and novel indications

Conference Website

Speaker/Participant: Hans J. Van der Vliet, M.D., Ph.D., Chief Scientific Officer, LAVA Therapeutics

Presentation: Bispecifics and T-cell Engagers session presentation – “Bispecific γδ-T cell engagers for the treatment of cancer”

Presentation Location: Channel 1 virtual room

Presentation Date: Monday, 7 March 2022

Presentation Time: 14.15 – 15.30 CET

Conference Website

Presenter: Stephen Hurly, President & Chief Executive Officer
Location: Virtual

Dr. Parren will present preclinical data on LAVA’s lead solid tumor Gammabody™ LAVA-1207 as well as new non-human primate data supporting the safety and tolerability profile of LAVA’s lead solid tumor Gammabody™ programs.

Presenter: Paul W.H.I. Parren, Ph.D., Executive Vice President, Head of Research and Development
Presentation Title: Bispecific Gamma-Delta T Cell Engagers Targeting PSMA for the Treatment of Prostate Cancer
Location: San Diego and virtual – Sapphire Session Room

Stephen Hurly, President and Chief Executive Officer at LAVA Therapeutics, will present a corporate overview at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 12, 2022 at 10:30 a.m. EST.

To view the agenda and presentations from our virtual symposium please visit The Antibody Society.

Stephen Hurly, president and chief executive officer at LAVA, will participate in a virtual fireside chat. The fireside chat will be available to conference attendees starting at 3:00 a.m. ET (08:00 GMT) on Thurs., Nov. 18 through 12:00 p.m. ET (17:00 GMT) on Fri., Nov. 19.

To register, please visit: Jefferies London Healthcare Conference.

Keynote Panel Discussion: Next generation antibody therapeutics: discovery, development and beyond
Panel Discussion Date/Time: Tues., Nov. 9, 2021 at 10:00 CET

Presentation: Bispecifics & Multispecifics Track – Bispecific gamma-delta T cell engagers
Presentation Date/Time: Tues., Nov. 9, 2021 at 14:00 CET

Session Chair: Bispecifics & Multispecifics Track
Session Date/Time: Tues., Nov. 9, 2021 at 15:40 CET